← Back to news

Markets

Tempus AI Retains Buy Rating as Canaccord Adjusts Price Target to $95 After Q3 Beat

Y

Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat

Y

Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8

Y

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch

Y

Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business

Y

Piper Sandler Lifts Hinge Health Target to $71 After Q3 Beat and Raised Guidance

Y

Mizuho Raised Waystar Target to $50, Reaffirmed Outperform After Q3 Strength

Y

UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3

Y

Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth

Y

Morgan Stanley Lifted GE HealthCare Target to $80 in Late October, Citing Strong Orders and Backlog

Y

Erste Group Downgrades Arista Networks (ANET) Stock to Hold from Buy

Y

Citi Raises PT on Lam Research (LRCX) Stock

Y

William Blair Maintains Bullish Stance on Costco Wholesale (COST) Stock

Y

CMB International Securities Maintains Buy Rating on ServiceNow (NOW) Stock

Y

Evercore ISI Raises PT on Advanced Micro Devices (AMD) Stock

Y

Salesforce (CRM) Signs Definitive Agreement for Acquisition of Spindle AI

Y

Tigress Financial Raises PT on Mastercard (MA) Stock

Y

Bank of America Securities Maintains Buy Rating on Taiwan Semiconductor Manufacturing (TSM) Stock

Y

BofA Maintains Buy Rating on NVIDIA (NVDA) Stock

Y

Microsoft (MSFT) Expands Data Center Build-out with an AI Super Factory, Reports WSJ

Y

A slowing wartime economy pushes the Kremlin to tap consumers for revenue

Y

BNP Paribas Upgrades Comcast (CMCSA) to Neutral

Y

UBS Lifts Stanley Black & Decker (SWK) Target, Reaffirms Buy Rating

Y

Goldman Sachs Cuts Brown & Brown (BRO) Price Target, Keeps Neutral Rating

Y

Mondelez (MDLZ) Target Lowered to $62 as Analyst Maintains Neutral Stance

Y

Morgan Stanley Trims Clorox (CLX) Price Target After Soft Q1 Performance

Y

JPMorgan Lowers Costco (COST) Price Target to $1,025, Maintains Overweight Rating

Y

Bernstein Raises CNI Price Target to $109.44, Maintains Market Perform Rating

Y

Susquehanna Raises Qualcomm (QCOM) Price Target to $210 on Strong Handset Momentum

Y

Scotiabank Initiates Coverage on Bristol Myers (BMY) with Sector Perform Rating and $45 Target

Y

Piper Sandler Lowers Chevron (CVX) Price Target to $168, Keeps Overweight Rating

Y

BMO Capital Raises Enbridge (ENB) Price Target to C$67, Maintains Market Perform rating

Y

Scotiabank Analyst Sees Opportunity in Large Cap Biopharma, Keeps Outperform on GILD

Y

Morgan Stanley Reaffirms Overweight Rating on Bank of America (BAC) After Investor Day

Y

Erste Group Upgrades Cisco (CSCO) to Buy After Strong Start to Fiscal 2026

Y

Johnson & Johnson (JNJ) Emerges as Scotiabank’s Top Pick for Curative Treatments

Y

Floating Oil Storage Surge Puts Market Balance on Edge

Y

Tulsa roofer fumes at State Farm for denying claims, losing him thousands. Lawyer calls out 2 tactics to watch out for

Y

A Single Father Owes $140,000 In Credit Cards With Rates Up To 32%. Dave Ramsey Host Asks, 'Can You Take Your Kid With You To Do DoorDash?'

Y

3 Investing Lessons From Warren Buffett's November Letter to Berkshire Hathaway Shareholders

Y

2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income

Y

Ex-Fed official faced ethics probe on illegal stock trades

Y

Why Lumen Stock Plummeted This Week

Y

Former Fed governor's stock trades violated the central bank's ethics rules

Y

Sundar Pichai responds to Polymarket predicting Gemini 3 update

Y

JPMorgan doesn’t want to pay Frank founder Charlie Javice’s legal bills

Y

Warren Buffett’s Berkshire snaps up major tech stock, trims favorite

Y

Is Crypto in a Bear Market Now? A Full Market Structure Assessment

Y

Harvard Endowment Takes Rare Leap Into Bitcoin With $443M Bet on BlackRock's IBIT

Y

Europe Gauges Fallout From Trump’s Year of Trade Chaos

Y